Search Results - "Sutcharitchan, P"

Efficacy and safety of deferasirox at low and high iron burdens: results from the EPIC magnetic resonance imaging substudy by Porter, J. B., Elalfy, M. S., Taher, A. T., Aydinok, Y., Chan, L. L., Lee, S.-H., Sutcharitchan, P., Habr, D., Martin, N., El-Beshlawy, A.

“…The effect of deferasirox dosing tailored for iron burden and iron loading based on liver iron concentration (LIC) was assessed over 1 year in less versus more…”
Get full text

Prognostic factors of green pit viper bites by Rojnuckarin, P, Mahasandana, S, Intragumthornchai, T, Sutcharitchan, P, Swasdikul, D

“…Clinical features of green pit viper bites vary from asymptomatic to fatal bleeding. Antivenin promptly reverses the coagulopathy but has considerable adverse…”
Get more information

Severity of sarcopenia and associated factors in adults with transfusion-dependent thalassemia by Talkijkul, P., Lakananurak, N., Sotananan, S., Sutcharitchan, P., Wattanachanya, L.

Get full text

Combined effects of exercise and nutritional interventions on sarcopenia and its associated quality of life in transfusion-dependent thalassemia patients: a single-arm, open-label study by Talkijkul, P., Houngngam, N., Santisitthanon, P., Vitoonpong, T., Lakananurak, N., Kingpetch, K., Buranasupkajorn, P., Pongchaiyakul, C., Sutcharitchan, P., Wattanachanya, L.

Get full text

Reverse Dot-Blot Detection of the African-American β-Thalassemia Mutations by Sutcharitchan, P., Saiki, R., Huisman, T.H.J., Kutlar, A., McKie, V., Erlich, H., Embury, S.H.

“…DNA-based diagnosis of the β thalassemias provides accuracy to newborn screening, genetic counseling, and prenatal diagnosis. However, the use of polymerase…”
Get full text

Experience with continuous infusion of recombinant activated factor VII in the Asia-Pacific region by McPherson, J, Sutcharitchan, P, Lloyd, J, Street, A, Nelleman Jorgensen, L, Yang, S I

“…There is increasing interest in continuous infusion of recombinant activated factor VII (rFVIIa) as a convenient and safe alternative to intermittent bolus…”
Get more information

Risk factors for symptomatic venous thromboembolism in Thai hospitalised medical patients by Rojnuckarin, Ponlapat, Uaprasert, Noppacharn, Vajragupta, Laddawan, Numkarunarunrote, Numphung, Tanpowpong, Nathaporn, Sutcharitchan, Pranee

“…Thromboprophylaxis for venous thromboembolism (VTE) failed to reduce overall mortality in hospitalised medical patients. As a VTE prediction model for Asians…”
Get more information

A Predictive Model for Life-Threatening Neutropenia and Febrile Neutropenia after the First Course of CHOP Chemotherapy in Patients with Aggressive Non-Hodgkin's Lymphoma by Intragumtornchai, Tanin, Sutheesophon, Jutharat, Sutcharitchan, Pranee, Swasdikul, Daratana

“…The purpose of this study was to develop a model for predicting the occurrence of life-threatening neutropenia (LN, ANC ≤ 0.5 × 109/1) and febrile neutropenia…”
Get full text

Hemoglobin h disease classification by isoelectric focusing : Molecular verification of 110 cases from thailand by SUTCHARITCHAN, Pranee, WEN WANG, SETTAPIBOON, Rung, AMORNSIRIWAT, Supaporn, TAN, Arnold S. C, CHONG, Samuel S

Get full text

Reverse dot-blot detection of Thai beta-thalassaemia mutations by Sutcharitchan, P, Saiki, R, Fucharoen, S, Winichagoon, P, Erlich, H, Embury, S H

“…Pending curative therapy, newborn screening and prenatal diagnosis are essential to the management of beta thalassaemia. Diagnosis using electrophoretic…”
Get more information

Advances in molecular diagnosis of inherited hemoglobin disorders by Sutcharitchan, P, Embury, S H

“…Molecular diagnosis for inherited disorders of hemoglobin production has been driven largely by the need for improved prenatal diagnosis. In turn, DNA-based…”
Get more information

Prognostic Significance of the Immunophenotype Versus the International Prognostic Index in Aggressive Non-Hodgkin's Lymphoma by Intragumtornchai, Tanin, Rotnakkarin, Ponlapat, Sutcharitchan, Pranee, Wannagrairoj, Pongsak

“…The International Prognostic Index (IPI) is currently the most widely accepted prognostic factor system for patients with aggressive non- Hodgkin's lymphoma…”
Get full text